Advanced Cell Immunotherapy Unit (ACIU)

ACIU represents excellent non-commercial production unit approved by National Regulatory Agency for development and production of advanced therapy medicinal products (ATMP) including dendritic cells (DB), activated expanded lymphocytes (AEL), and mesenchymal stromal cells (MSC). All manufacturing and production-control activities in ACIU are carried out in accordance with the principles of Good Manufacturing Practice (GMP Quality), to the extent of the authorization for the manufacturer of investigational medicinal products within the clinical trial. This GMP Unit is a unique facility within the academic sector, and the cooperation with LRI CZECRIN allows to improve the effective translation of academic discoveries to further clinical investigation steps.

ACIU currently manufacture two ATMP products:

The ACIU team consists of experts with experience in pharmaceutical manufacture, with expertise in cell biology and immunology, and/or in diagnostic methods.

Head of the ACIU

Prof. Dalibor Valik, MD, PhD. DABCC

Head of Quality Control (QC)

Assoc. Prof. Lenka Zdrazilova Dubska, Ph.D.

Head of GMP production unit

Katerina Pilatova, MSc., Ph.D

Qualified Person (QP)

Lucie Flajsarova, Ing.

Members:

Collaborations:

You are running an old browser version. We recommend updating your browser to its latest version.

More info